首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7431篇
  免费   288篇
  国内免费   82篇
耳鼻咽喉   90篇
儿科学   123篇
妇产科学   141篇
基础医学   765篇
口腔科学   287篇
临床医学   618篇
内科学   2279篇
皮肤病学   87篇
神经病学   616篇
特种医学   252篇
外科学   1197篇
综合类   19篇
一般理论   1篇
预防医学   298篇
眼科学   74篇
药学   348篇
  1篇
中国医学   6篇
肿瘤学   599篇
  2024年   68篇
  2023年   147篇
  2022年   270篇
  2021年   487篇
  2020年   304篇
  2019年   319篇
  2018年   352篇
  2017年   244篇
  2016年   294篇
  2015年   302篇
  2014年   390篇
  2013年   436篇
  2012年   627篇
  2011年   554篇
  2010年   307篇
  2009年   296篇
  2008年   404篇
  2007年   367篇
  2006年   335篇
  2005年   271篇
  2004年   219篇
  2003年   181篇
  2002年   135篇
  2001年   42篇
  2000年   35篇
  1999年   36篇
  1998年   31篇
  1997年   16篇
  1996年   17篇
  1995年   16篇
  1994年   13篇
  1992年   17篇
  1991年   16篇
  1990年   17篇
  1989年   22篇
  1988年   24篇
  1987年   19篇
  1986年   17篇
  1985年   14篇
  1980年   7篇
  1979年   10篇
  1978年   10篇
  1977年   8篇
  1974年   14篇
  1972年   8篇
  1971年   10篇
  1970年   9篇
  1969年   9篇
  1968年   7篇
  1966年   9篇
排序方式: 共有7801条查询结果,搜索用时 62 毫秒
91.
92.
The phenotype of infused cells is a major determinant of Adoptive T-cell therapy (ACT) efficacy. Yet, the difficulty in deciphering multiparametric cytometry data limited the fine characterization of cellular products. To allow the analysis of dynamic and complex flow cytometry samples, we developed cytoChain, a novel dataset mining tool and a new analytical workflow. CytoChain was challenged to compare state-of-the-art and innovative culture conditions to generate stem-like memory cells (TSCM) suitable for ACT. Noticeably, the combination of IL-7/15 and superoxides scavenging sustained the emergence of a previously unidentified nonexhausted Fit-TSCM signature, overlooked by manual gating and endowed with superior expansion potential. CytoChain proficiently traced back this population in independent datasets, and in T-cell receptor engineered lymphocytes. CytoChain flexibility and function were then further validated on a published dataset from circulating T cells in COVID-19 patients. Collectively, our results support the use of cytoChain to identify novel, functionally critical immunophenotypes for ACT and patients immunomonitoring.  相似文献   
93.
Clinical and Experimental Medicine - We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC),...  相似文献   
94.
This article describes a technique for surgically extruding severely compromised roots needing prosthetic rehabilitation. Unlike previously described approaches, the technique does not require advanced clinical skills or equipment, may reduce the risk of tooth or bone fracture during the luxation maneuvers, and does not seem to interfere with the alveolar socket healing process.  相似文献   
95.
Hyaline fibromatosis syndrome is an autosomal recessive disease caused by mutations in ANTXR2, a gene involved in extracellular matrix homeostasis. Sixty percent of patients carry frameshift mutations at a mutational hotspot in exon 13. We show in patient cells that these mutations lead to low ANTXR2 mRNA and undetectable protein levels. Ectopic expression of the proteins encoded by the mutated genes reveals that a two base insertion leads to the synthesis of a protein that is rapidly targeted to the ER‐associated degradation pathway due to the modified structure of the cytosolic tail, which instead of being hydrophilic and highly disordered as in wild type ANTXR2, is folded and exposes hydrophobic patches. In contrast, one base insertion leads to a truncated protein that properly localizes to the plasma membrane and retains partial function. We next show that targeting the nonsense mediated mRNA decay pathway in patient cells leads to a rescue of ANTXR2 protein in patients carrying one base insertion but not in those carrying two base insertions. This study highlights the importance of in‐depth analysis of the molecular consequences of specific patient mutations, which even when they occur at the same site can have drastically different consequences.  相似文献   
96.
97.
98.
99.
100.

Background

Proximal inter-phalangeal (PIP) joint arthrodesis today represents the standard treatment for structured hammertoes; however, recently, a lot of new intramedullary devices for the fixation of this arthrodesis have been introduced. The purpose of this work is to look at the currently available devices and to perform a review of the present literature.

Materials and methods

A literature search of PubMed/Medline and Google Scholar databases, considering works published up until September 2014 and using the keywords: hammertoe, arthrodesis, PIP joint, fusion, intramedullary devices, and K-wire, was performed. The published papers were included in the present study only if they met the following inclusion criteria: English articles, arthrodesis of PIP joints for hammertoes with new generation intramedullary devices, series with n > 10. Studies using absorbable pins or screws that are considered as another kind of fixation that involved more than one articulation, as well as comments, letters to the editor, or newsletters were excluded.

Results

Nine publications were included. Of the patients’ reports, 93–100 % were good or excellent concerning satisfaction. Radiological arthrodesis was achieved in 60.5–100 % of cases. Three of the publications compared the new devices with the K-wire. Of these three articles, two employed the traditional technique and one the buried technique. The AOFAS score, evaluated in three publications, showed a delta of 19, 45 and 58 points. Major complications, which required a secondary surgical revision, were between 0 and 8.6 %. The complications of the K-wire and the new devices were similar; also the reoperation rate was close to equal (maximal difference 2 %). On the other hand, these kinds of devices definitely have a higher price, compared to the K-wire.

Conclusion

The use of these new devices provides good results; however, their high price is currently a problem. For this reason, cost-benefit studies seem to be necessary to justify their use as standard treatment.

Level of evidence

Level III systematic review.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号